Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus.
Abbasi
F
F
Stanford University School of Medicine, Stanford, California, USA.
Asagmi
T
T
Cooke
J P
JP
Lamendola
C
C
McLaughlin
T
T
Reaven
G M
GM
Stuehlinger
M
M
Tsao
P S
PS
D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood*; D001786:Blood Glucose; D016022:Case-Control Studies; D002784:Cholesterol / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D004791:Enzyme Inhibitors / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors
D001786:Blood Glucose; D004791:Enzyme Inhibitors; C018524:N,N-dimethylarginine; D001120:Arginine; D002784:Cholesterol; D019001:Nitric Oxide Synthase